Li-Yuan Bai Selected Research

B7-H1 Antigen

1/2022

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Yuan Bai Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 01/2003
19	Adenocarcinoma 05/2024 - 01/2016
13	Breast Neoplasms (Breast Cancer) 03/2024 - 09/2011
11	Stomach Neoplasms (Stomach Cancer) 05/2024 - 04/2014
9	Squamous Cell Carcinoma of Head and Neck 10/2020 - 10/2010
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 03/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 04/2017
6	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2003
6	Mouth Neoplasms (Oral Cancer) 09/2019 - 10/2010
5	Hematologic Neoplasms (Hematological Malignancy) 04/2022 - 03/2004
5	Leukemia 03/2017 - 04/2006
4	Disease Progression 10/2021 - 01/2012
4	Carcinogenesis 02/2014 - 09/2011
3	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 12/2005
3	Esophageal Squamous Cell Carcinoma 06/2023 - 11/2008
3	Lymphoma (Lymphomas) 01/2023 - 09/2003
3	Anemia 01/2023 - 01/2019
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2022 - 03/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2020 - 12/2011
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024 - 01/2020
2	Vomiting 01/2023 - 05/2014
2	Nausea 01/2023 - 05/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2022 - 10/2021
2	Thrombocytopenia (Thrombopenia) 05/2022 - 10/2021
2	Splenomegaly 01/2022 - 01/2021
2	Sepsis (Septicemia) 01/2022 - 10/2021
2	Invasive Fungal Infections 01/2022 - 01/2018
2	Neutropenia 10/2021 - 12/2014
2	Inflammation (Inflammations) 07/2018 - 12/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2016 - 01/2013
2	Infections 02/2015 - 04/2006
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2015 - 05/2008
2	Bradycardia 05/2010 - 01/2010
1	Pathologic Complete Response 06/2023
1	Communicable Diseases (Infectious Diseases) 03/2023

Drug/Important Bio-Agent (IBA)

14	Gemcitabine FDA Link 03/2024 - 12/2005
10	Leucovorin (Folinic Acid)FDA Link 03/2024 - 01/2020
10	NivolumabIBA 10/2022 - 12/2017
8	Irinotecan (Camptosar)FDA LinkGeneric 03/2024 - 01/2021
8	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 01/2021
5	indole-3-carbinolIBA 01/2020 - 10/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2020 - 11/2013
4	(1- (4- chloro- 3- nitrobenzenesulfonyl)- 1H- indol- 3- yl)- methanolIBA 01/2020 - 10/2010
4	TriterpenesIBA 11/2017 - 01/2013
3	Immunoglobulin G (IgG)IBA 10/2023 - 12/2017
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 04/2014
3	Capecitabine (Xeloda)FDA Link 01/2022 - 12/2005
3	Immune Checkpoint InhibitorsIBA 07/2021 - 01/2020
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2018 - 01/2013
3	Phosphotransferases (Kinase)IBA 12/2015 - 02/2012
3	PhytochemicalsIBA 11/2013 - 10/2010
2	venetoclaxIBA 03/2024 - 01/2022
2	Azacitidine (5 Azacytidine)FDA Link 03/2024 - 01/2022
2	AntigensIBA 03/2024 - 09/2023
2	Monoclonal AntibodiesIBA 10/2023 - 12/2017
2	pembrolizumabIBA 10/2023 - 01/2022
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2022 - 03/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2019
2	RamucirumabIBA 10/2021 - 01/2019
2	SesquiterpenesIBA 04/2021 - 08/2020
2	ilimaquinoneIBA 04/2021 - 08/2020
2	VaccinesIBA 01/2021 - 04/2006
2	Cardiac GlycosidesIBA 10/2020 - 01/2019
2	Fingolimod Hydrochloride (FTY720)FDA Link 02/2020 - 01/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2018 - 02/2014
2	integrin-linked kinaseIBA 08/2016 - 09/2011
2	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 12/2014
2	Rituximab (Mabthera)FDA Link 02/2015 - 05/2008
2	AnthracyclinesIBA 12/2014 - 09/2003
2	liposomal doxorubicin (Doxil)FDA Link 12/2014 - 12/2005
2	Histone Deacetylase InhibitorsIBA 12/2011 - 08/2011
2	fludarabineIBA 05/2010 - 01/2010
1	PlatinumIBA 05/2024
1	130-nm albumin-bound paclitaxelIBA 03/2024
1	tryptanthrineIBA 03/2024
1	QuinazolinesIBA 03/2024
1	indoloquinazolineIBA 03/2024
1	Immunoconjugates (Immunoconjugate)IBA 03/2024
1	EpitopesIBA 03/2024
1	ClaudinsIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	zolbetuximabIBA 10/2023
1	hepatitis B virus X proteinIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	MicroRNAs (MicroRNA)IBA 09/2023
1	silmitasertibIBA 01/2023

Therapy/Procedure

26	Therapeutics 01/2023 - 10/2010
17	Drug Therapy (Chemotherapy) 05/2024 - 09/2003
5	Adjuvant Chemotherapy 05/2024 - 12/2014
4	Hematopoietic Stem Cell Transplantation 03/2024 - 03/2013
3	Stem Cell Transplantation 03/2024 - 05/2014
3	Gastrectomy 01/2023 - 01/2016
3	Transplantation 05/2014 - 03/2004
2	Salvage Therapy 01/2022 - 12/2005
2	Radiotherapy 01/2022 - 04/2020
2	Induction Chemotherapy 01/2018 - 02/2005
2	Homologous Transplantation 05/2014 - 02/2012
1	Neoadjuvant Therapy 06/2023
1	Traditional Medicine (Folk Remedies) 03/2023